Skip to main content
Premium Trial:

Request an Annual Quote

Atlas Genomics, Henry Schein Medical Ink Agreement to Provide NIPT, Carrier Screening

NEW YORK (GenomeWeb) – Atlas Genomics today announced an agreement with Henry Schein Medical for non-invasive prenatal testing (NIPT) and carrier screening.

Under the agreement, Henry Schein Medical, the US-based medical business of healthcare products firm Henry Schein, will offer its customers Atlas Genomics' tests, and its sales representatives will provide access to more than 25,000 OB-GYNs who currently conduct prenatal testing, Atlas said in a statement. Atlas, a privately held CLIA-certified high-complexity laboratory based in Seattle, will function as Henry Schein's laboratory for noninvasive prenatal testing and carrier screening.

NIPT, also called prenatal cell-free DNA (cfDNA) screening, identifies specific chromosomal abnormalities in a developing baby, including trisomy abnormalities. During prenatal cell-free DNA screening, DNA from the mother and fetus is extracted from a maternal blood sample to screen for the increased chance for specific chromosome problems, such as Down syndrome.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.